chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain on my left side / was in the hospital for almost four weeks / back, side, and half of my stomach on the left side; still on a walker and cane / not able to go back to my home because of the steps and even know I can not go up or downstairs; God to heal my back, side, and half of my stomach on the left side; God to heal my back, side, and half of my stomach on the left side; what was going on with me at the time, but 11-3-19 / mine agin in March 20 so I don't have to get any more; This case was reported by a consumer and described the occurrence of pain in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   In 2019, the patient received the 1st dose of Shingles vaccine. In March 2020, the patient received the 2nd dose of Shingles vaccine. In March 2020, not applicable after receiving Shingles vaccine and unknown after receiving Shingles vaccine, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced pain (serious criteria hospitalization), mobility decreased (serious criteria hospitalization), back pain (serious criteria hospitalization) and stomach pain (serious criteria hospitalization). On an unknown date, the outcome of the pain, mobility decreased, back pain, stomach pain and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the pain, mobility decreased, back pain and stomach pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient for himself/herself. The age at vaccination was not reported. The age group was not reported but was captured as an adult as per vaccine indication. The patient stated that he/she did not know what was going on but on 11th March he/she went to his/her doctor to find out what was going on with the pain on patient's left side. The patient drove himself/herself, was in the physician's office maybe for 10 minutes and they called to go in the room, and the next thing patient knew was he/she was in the emergency room of the hospital and then was in the hospital for almost four weeks and the patient was still on the walker and cane as of 30th April 2021. The patient was not able to go back to his/her home because of the steps and even knew that he/she could not go up or downstairs. The patient had two months after he/she got out, and then the patient received the vaccine again in March 20, almost late by a year which led to lengthening of the vaccination schedule. The patient was on a walker. The patient stated there was nothing they could give for his/her pain that helped him/her and it was the worst thing and lasted about four or five weeks after the patient came to his/her sisters house.  For three months three times a week the physiotherapist, occupational therapist and the nurse came to work with the patient.  The patient prayed all the time to the God to heal his/her back, side, and half of the stomach on the left side.
Presented to the ED for dizziness that she described as her head spinning, worsening with standing relieved by laying down, headache but no other focal neuro deficits.  Patient with dizziness without any other focal neurological deficit.  Initial CT scan without acute intracranial pathology neither ischemia nor hemorrhage. CT angio head, neck without significant stenosis. MRI without acute infarct. Neurologist evaluation done and recommended secondary stroke prevention with xarelto. EKG with bradycardia sinus rhythm and negative initial troponin. Will monitor on telemetry to assess ongoing arrhythmias. Patient now reported hx of afib, started on AC again. labs unremarkable.  Tested positive for COVID but remain asymptomatic and hypoxic. dizziness could be related to COVID. 2D echo preserved EF without valvulopathy. grade 1 diastolic dysfunction TSH normal. will follow orthostatic evaluation. PT/OT cleared patient for home.  Discharged 1/31/22.  Previously vaccinated with Moderna - 3/10/21 & 4/12/21.
"Negligible side effects" after all the doses, except for her arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION ("Negligible side effects" after all the doses, except for her arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Arthritis. Concurrent medical conditions included Blood pressure high.   On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION ("Negligible side effects" after all the doses, except for her arm). At the time of the report, VACCINATION COMPLICATION ("Negligible side effects" after all the doses, except for her arm) outcome was unknown.            Patient used to take an immunosuppressant drug for a long time but stopped after the pandemic started. No treatment medications were not provided.   This case was linked to MOD-2021-325478, MOD-2021-325512 (Patient Link).
Within 5 minutes had a headache; metallic taste in mouth; jaw muscles felt tight; shoulder muscles felt tight; throat tightened up.; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: en6203) via an unspecified route of administration in the left arm on 23Mar2021 at 13:15 (at the age of 48-year-old), as single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications included indapamide (MANUFACTURER UNKNOWN), potassium chloride (MANUFACTURER UNKNOWN) vitamin C (MANUFACTURER UNKNOWN) and vitamin (MANUFACTURER UNKNOWN). The patient had allergies to computed tomography (CT) contrast dye, and Celecoxib (CELEBREX). Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 at 13:15, within 5 minutes the patient experienced headache and got a strange medicine/metallic taste in mouth, a few minutes later, jaw and shoulder muscles felt tight and throat tightened up. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient received treatment with 25mg of benadryl for the adverse event. The clinical outcome of within 5 minutes headache and got a strange medicine/metallic taste in mouth, jaw and shoulder muscles felt tight and throat tightened up was resolving. No follow-up attempts are possible; No further information is expected.
Trouble sleeping; Blood sugar levels were elevated; Cannot hardly walk; Weak in both knees; Pain in/ knee; Pain in the top of both legs; Pain radiating from chest; Pain radiating from chest, underarm, to back; Pain radiating from chest, underarm, to back; This case was reported by a consumer via call center representative and described the occurrence of difficulty sleeping in a 87-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included methylprednisolone for knee pain and leg pain.   The patient's past medical history included shingles (had shingles in 1st January 2021). Concomitant products included Herpes zoster (Shingrix).   On 12th July 2021, the patient received the 2nd dose of Shingrix. In July 2021, the patient started methylprednisolone at an unknown dose and frequency. On 12th July 2021, less than a day after receiving Shingrix, the patient experienced difficulty sleeping, blood sugar increased, walking difficulty, lower extremities weakness of, knee pain, leg pain, chest pain, axillary pain and back pain. The patient was treated with lidocaine (Lidocaine Cream). The action taken with methylprednisolone was unknown. On an unknown date, the outcome of the difficulty sleeping, walking difficulty, lower extremities weakness of, knee pain, leg pain, chest pain, axillary pain and back pain were not recovered/not resolved and the outcome of the blood sugar increased was recovered/resolved.   It was unknown if the reporter considered the difficulty sleeping, blood sugar increased, walking difficulty, lower extremities weakness of, knee pain, leg pain, chest pain, axillary pain and back pain to be related to Shingrix.  Additional details were reported as follows: The consumer reported that he had shingles. The patient received his first dose of shimgrix with no adverse events. Then patient received second dose of shingrix and experienced pain in the top of both legs, pain in his left knee, and pain radiating across his chest to his underarm to his back along the same path as his shingles outbreak. The consumer states that he was weak in both knees and cannot hardly walk, and has trouble sleeping.  The consumer visited a HCP and was given a steroid shot, lidocaine cream for his knee, and oral Methylprednisolone 4mg. The consumer stated that as a result of the steroids his blood sugar levels were elevated but have now come back down to normal. Consented to follow up. ER Visit Required.
Pain at injection site, nausea, vomiting, chest pain, elevated heart rate, occasional shortness of breath. Side effects began 2/8/22 and were first reported by child around 9:00 pm.
Information has been received from a pharmacy intern concerning a 76 year old female with no medical history or known drug allergies who on 24-APR-2008 was vaccinated subcutaneously into the right arm with a 0.65 mL dose of zoster vaccine live (Oka/Merck) (Lot #659614/0161X). There was no concomitant medication or other vaccinations administered on that day. On 24-APR-2008, by the time the patient arrived home, she had numbness and tingling of both hands. An hour later, she called the pharmacy and stated she had developed swelling, redness and itching of both hands. The patient denied any allergies including neomycin and gelatin. No laboratory diagnostic studies were performed. As of 24-APR-2008, the patient had not recovered. No product quality complaint was involved. Additional information has been requested.  09/24/2008 This is in follow-up to report(s) previously submitted on 6/24/2008. Follow-up information was received on 30-JUN-2008 from a doctor of pharmacy concerning a 76 year old female with no known pre-existing allergies, birth defects or medical conditions who on 24-APR-2008 was vaccinated in the right arm with a first dose of ZOSTAVAX (Oka/Merck) (Lot #659614/0161X). On 24-APR-2008, after administering the vaccine, the patient called to say she had redness, swelling, numbness, tingling and itching in both hands. Within 24 hours the patient recovered from the events. The patient also claimed that her daughter had "similar" reactions when receiving any type of shot. Additional information is not expected.
Information has been received from a certified medical assistant referring to a patient of unknown age and gender. The medical assistant reported that the patient was vaccinated the first dose in the rotavirus vaccine series with ROTARIX (dose and route not reported) on 14-DEC-2015 at a different location and then the patient came to the current office on 11-MAR-2016 and was vaccinated with second dose in the rotavirus vaccine series with ROTATEQ (lot# L027726, expiration date 10-MAY-2017; dose and route not reported) (interchange of vaccine products). No adverse effects were reported. Additional information has been requested.
Itching terribly; This is a spontaneous report from a contactable consumer (patient). This 72-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 (lot number: EL3249 and expiry date unknown) at a single dose and then the second dose via an unspecified route of administration on 09Feb2021 13:30 (lot number: EL9261 and expiry date unknown) at a single dose for COVID-19 immunisation. There were no medical history and concomitant medications. She got the first shot on 19Jan2021 and about a week and half later, she started itching terribly for about 48 hours and was off and on, mostly at night. She got her second dose of the vaccine Tuesday, 09Feb2021 13:30, and she started itching terribly Tuesday night, around 19:00-19:-30 and she had been itching since. It is ongoing but has gotten better because she has been taking Benadryl. She called the place where she got the shot done and they said it was not a side effect, to call her internal medicine, doctor and she called them and they told to call Pfizer because they do believe it is a side effect. She is trying to clarify if itching is associated with the product. Outcome of the event was recovering.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021 at 10:55 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Apr-2021 at 10:55 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  The age of patient was provided as 36.04.  It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  On 27-Apr-2021, Excursion time was 09 AM temperature was 35, total doses given for the day was 42, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 19-Apr-2021, vial was moved to clinic on 27-Apr-2021. 08 vials were sent to clinic. Vaccine BUD date was 19-May-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. The temperature recordings were taken by using a Fisher brand traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  No treatment information was provided.
booster shot kicked back at me harder than either first two dosages; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (booster shot kicked back at me harder than either first two dosages) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Type 2 diabetes mellitus from 2016 to 2017 and Weight loss (Lost 50 pounds).   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION COMPLICATION (booster shot kicked back at me harder than either first two dosages). On 03-Sep-2021, VACCINATION COMPLICATION (booster shot kicked back at me harder than either first two dosages) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: 115 (Low) never gone above 115 an hour after eating..         A1C had consistently tested below 5.0 since 2017. On 23-SEP-2021 Eyesight was 20/20.  Concomitant medications and Treatment information were not provided.   Reporter did not allow further contact
A filling pop in her mouth; Headache; Nausea; This is a spontaneous report from a contactable consumer or other non hcp (Patient) from a Pfizer sponsored program.  A 39-years-old female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 10Apr2021 as single dose for covid-19 immunisation. Medical history included has some allergy issues and is experiencing a runny nose and post nasal drip and an irritated sore throat, She is unsure if its allergies or a cold from an unknown date and unknown if ongoing. Historical vaccine included first dose of BNT162B2 for covid-19 immunization. The patient concomitant medications were not reported. It was reported that patient set to receive her first dose of the Pfizer vaccine today but has some allergy issues and is experiencing a runny nose and post nasal drip and an irritated sore throat. She is unsure if its allergies or a cold. Can she still receive the vaccine today and wanted to know it be efficacious. She is not currently taking any medications for her allergy symptoms. Upon date 12Apr2021 it was reported that patient received second dose and experienced a filling pop in her mouth and has a dentist appointment tomorrow morning. Asked if it is okay to have the appointment or in case they will give medication like Novocaine after receiving the second dose. Upon date 13Apr2021 it was reported that She has an upcoming dental appointment, and may need some fillings. She wants to know if it is safe to have the dental procedure done. Also reported she has been experiencing a headache that has been coming and going and some nausea. Neither symptom lasts long. She was asking if this could be because of the second dose, and how long the symptoms could last. The outcome for the events was reported as unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot been obtained
Headache, Arthralgia, Fever, CoughWheeze, UrticariaPruritus, NauseaVomiting, sore arm Narrative:  Fever 102, arthralgia, nausea, headache, itching and rash on stomach and back, wheezing, arm pain; took tylenol, feels better.
On 03/06/2021, my rib on my right side felt broken, but there was no bruising or discoloration. It was just painful. And I had no injury. What continues to be a problem are my hands and wrist and that started on 03/14/2021. They were very swollen, hot, and very painful to do anything like drive a a car and brush my teeth. I couldn't lift anything. I didn't know if the strength problem was because of the pain. I am a physician so I tried Aleve and I had wrist splints thinking it was tendinitis. The wrist splints made it worse and the Aleve didn't do anything. So I started using ice packs on my wrist and hands, that seemed to help. If I didn't have ice packs, my hands were swollen, and pink, and hot. It was temporary relief while I had the ice packs. A cell mediated immunity when the body over reacts to something, an autoimmune reaction. I saw a doctor on 04/02/2021, he did x-rays and started me on Prednisone. It took for several weeks and I stopped it. for a few weeks I felt better, my hands were less swollen. but a few weeks after the pain started again. I saw the rheumatologist, on 07/07/2021, I had very abnormal blood test, CRP  done in April and July. I saw, her again on the 07/21/2021 and she started me on plaquenil which has not helped me at all. Now I started taking Aspirin it has reduced the swelling and the pain but I still have my joints are still swollen. I have another appointment to see what they figure out. It is still in progress. The test for rheumatoid arthritis are negative. The Aspirin is helping and my hands are not hot anymore.  I can't do the things I used to do like brush my teeth, but I am managing on the Aspirin. The ultrasound showed it was not permanent damage.
Seizures and migraine headaches. ER several times. Hospitalized 4 days for tests - MRI, EEG - diagnosis of seizure disorder - had no problem before GARDASIL.
rash; Hives; This case was reported by a other health professional via call center representative and described the occurrence of rash in a 17-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA268A, expiry date 31st March 2021) for prophylaxis.   Previously administered products included Menveo (received on 1st September 2015).   On 31st August 2020, the patient received Menveo. On 4th September 2020, 4 days after receiving Menveo, the patient experienced rash and hives. On an unknown date, the outcome of the rash and hives were recovered/resolved.   It was unknown if the reporter considered the rash and hives to be related to Menveo.  Additional details were provided as follows: The patient received Menveo and as per the report received from the Emergency Room, the patient was seen at the Emergency room because of rash and hives, which might had developed a day or two earlier.   The HCP did not had information about the location of the hives and rash.  The patient was treated and discharged and was not admitted.  The reporter consented to follow up.
Redness, swelling, and itching on site. Size of a baseball on 15Dec11, hard red center. Size of a softball on 16Dec11. About 1 inch width, 2 1/2 inch length.
In January 2023, I had rapid onset fever and chills with nausea, vomiting and diarrhea. My diarrhea lasted for about 2-3 weeks. My fatigue lasted for about one week. I went to urgent care after the 4th days. I was diagnosed with Shigellosis. I began an antibiotic, Z-Pack after two weeks. I was feeling better after a total of three weeks.